While a causal link between urogenital schistosomiasis
(
Schistosoma haematobium
) and anaemia is well
established, quantitative associations between infection
intensity and haemoglobin levels across endemic communities,
at fine spatial scales, remain insufficiently characterized.
As part of the broader Hybridisation in Urogenital
Schistosomiasis (HUGS) investigation, we studied the
micro-epidemiology of anaemia within two study communities
in southern Malawi where
S. haematobium
remains endemic.
Urine samples were examined by microscopy to quantify
S. haematobium
infection intensity, categorised as
low (0–9 eggs/10 mL), moderate (10–49 eggs/10 mL), and
heavy (≥50 eggs/10 mL). Individual haemoglobin concentrations
were measured using a HemoCue photometer in 1,149 participants
from Samama village (Mangochi District) and 977 participants
from Mthawira village (Nsanje District). Linear geostatistical
models incorporating individual-level characteristics and
spatial covariates were used to estimate anaemia prevalence
at fine geographical scales.
Moderate anaemia (Hb 80–109 g/L) was most prevalent among
children aged 6–12 years (45.30% in Samama and 39.54% in
Mthawira), while severe anaemia was more frequent among
adults aged ≥19 years in both villages. Increasing
S. haematobium
infection intensity was associated
with lower haemoglobin levels, with individuals harbouring
heavy infections being at greater risk of moderate-to-severe
anaemia. Spatial modelling revealed longer-range spatial
correlation in Nsanje (ϕ = 66.7 km) than in Mangochi
(ϕ = 25.5 km), indicating more spatially persistent risk
in Nsanje and more localised heterogeneity in Mangochi.
Predicted anaemia prevalence among female children aged
6–12 years with moderate infection intensity ranged from
25–65% in Mangochi and 64–76% in Nsanje.
At the micro-epidemiological level,
S. haematobium
infection intensity was associated with the severity of
anaemia, with substantial spatial heterogeneity within and
between villages. Identification of high-risk clusters
supports targeted interventions, including stepped-up
preventive chemotherapy, improved water and sanitation,
and iron supplementation.